ALUR - יחס חוב להיוון בספרים Allurion Corp

Allurion Technologies (ALUR) is recognized as a global leader in non-surgical obesity treatment due to its innovative swallowable balloons. The business relies on partnerships with clinics to implement wellness programs, although aggressive marketing requires strict capital management. The GURU.Markets portal features a capital structure trend for debt-to-book capitalization, where 0.00 shows the current value of the metric, confirming the company's financial stability.

Scaling sales of innovative gastric balloons requires significant capital expenditures in digital infrastructure. This ratio compares total borrowed funds to the book value of equity. The metric determines the extent to which the financial stability of Allurion Technologies (ALUR) depends on external financing. A decrease in this value minimizes default risks but may signal conservative growth. By analyzing the debt-to-equity capitalization ratio, an investor assesses the maturity of the business model.